Scarica l'app Stockscreener
17.35
0.46%
-0.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KVUE Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$17.43
Aprire:
$17.47
Volume 24 ore:
12.79M
Relative Volume:
0.33
Capitalizzazione di mercato:
$33.26B
Reddito:
$15.12B
Utile/perdita netta:
$1.47B
Rapporto P/E:
22.71
EPS:
0.764
Flusso di cassa netto:
$1.72B
1 W Prestazione:
+1.23%
1M Prestazione:
-3.40%
6M Prestazione:
+4.20%
1 anno Prestazione:
-20.67%
Intervallo 1D:
$17.30
$17.56
Intervallo di 1 settimana:
$16.64
$17.56
Portata 52W:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Nome
Kenvue Inc
Settore
Industria
Telefono
908-874-1200
Indirizzo
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, KMB
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.35 | 33.26B | 15.12B | 1.47B | 1.72B | 0.764 |
PG
Procter Gamble Co
|
145.16 | 337.35B | 85.26B | 16.53B | 14.85B | 6.7488 |
UL
Unilever Plc Adr
|
58.34 | 127.41B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
84.34 | 67.67B | 20.38B | 2.26B | 3.63B | 2.6214 |
KMB
Kimberly Clark Corp
|
97.28 | 32.29B | 17.23B | 1.75B | 1.64B | 6.0654 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Downgrade | Jefferies | Buy → Hold |
| 2025-10-29 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | Aggiornamento | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | Iniziato | Redburn Atlantic | Neutral |
| 2025-03-24 | Iniziato | Evercore ISI | In-line |
| 2025-01-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-09-24 | Iniziato | Jefferies | Buy |
| 2024-09-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | Ripresa | Citigroup | Neutral |
| 2024-04-11 | Iniziato | Bernstein | Underperform |
| 2024-04-03 | Iniziato | William Blair | Mkt Perform |
| 2024-03-01 | Ripresa | Goldman | Neutral |
| 2023-11-17 | Iniziato | Piper Sandler | Neutral |
| 2023-09-11 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2023-09-07 | Iniziato | Canaccord Genuity | Buy |
| 2023-09-06 | Iniziato | Argus | Hold |
| 2023-08-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-25 | Iniziato | Edward Jones | Buy |
| 2023-06-01 | Iniziato | HSBC Securities | Hold |
| 2023-05-30 | Iniziato | BofA Securities | Buy |
| 2023-05-30 | Iniziato | Citigroup | Neutral |
| 2023-05-30 | Iniziato | Deutsche Bank | Hold |
| 2023-05-30 | Iniziato | Exane BNP Paribas | Neutral |
| 2023-05-30 | Iniziato | Goldman | Neutral |
| 2023-05-30 | Iniziato | JP Morgan | Overweight |
| 2023-05-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Iniziato | UBS | Neutral |
Mostra tutto
Kenvue Inc Borsa (KVUE) Ultime notizie
HF Advisory Group LLC Purchases 74,215 Shares of Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark To Acquire Kenvue In Massive $48.7B Merger - MSN
Massachusetts Financial Services Co. MA Reduces Position in Kenvue Inc. $KVUE - MarketBeat
RBC Capital Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $21 - Moomoo
Alpha Omega Wealth Management LLC Sells 167,069 Shares of Kenvue Inc. $KVUE - MarketBeat
Could Buying This Dividend Pharma Stock Today Set You Up for Life? - The Motley Fool
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Sonoma Pharmaceuticals and Kenvue Brands Sign Manufacturing and Supply Agreement for Microcyn® Technology Products Through 2027 - Minichart
Sonoma Pharmaceuticals (SNOA) signs Kenvue U.S. Microcyn manufacturing and supply deal - Stock Titan
OFI Invest Asset Management Invests $22.83 Million in Kenvue Inc. $KVUE - MarketBeat
Oak Thistle LLC Purchases Shares of 90,615 Kenvue Inc. $KVUE - MarketBeat
KVUE Stock Price, Quote & Chart | KENVUE INC (NYSE:KVUE) - ChartMill
Kenvue Inc. stock rises Wednesday, outperforms market - MarketWatch
[ARS] Kenvue Inc. SEC Filing - Stock Titan
Kenvue (NYSE: KVUE) outlines Kimberly-Clark merger, 2025 pay and votes - Stock Titan
Kenvue Inc. stock falls Tuesday, underperforms market - MarketWatch
Kenvue Inc call volume above normal and directionally bullish - TipRanks
UBS Group Issues Pessimistic Forecast for Kenvue (NYSE:KVUE) Stock Price - MarketBeat
Kenvue price target lowered to $18 from $19 at UBS - TipRanks
Rep. Kevin Hern Sells Kenvue Inc. (NYSE:KVUE) Stock - MarketBeat
Kimberly-Clark Has Fallen 33%. Is KMB Stock Finally a Buy? - TIKR.com
Capricorn Fund Managers Ltd Takes $4.87 Million Position in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal - MSN
T. Rowe Price Spectrum Moderate Growth Allocation Fund's Kenvue Inc(KVUE) Holding History - GuruFocus
Kenvue Inc. (KVUE): A bull case theory - MSN
141,900 Shares in Kenvue Inc. $KVUE Bought by Cohen Capital Management Inc. - MarketBeat
Kenvue Inc. (KVUE) stock price, news, quote and history - Yahoo Finance UK
Kenvue Inc. (KVUE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Why (KVUE) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Kenvue Inc. stock falls Thursday, underperforms market - MarketWatch
Kenvue Inc. $KVUE Shares Bought by HF Advisory Group LLC - MarketBeat
Jeffrey Smith (KVUE) grows deferred share units to 15,123.688 - Stock Titan
Here's Why Kenvue (KVUE) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Kenvue Defends ORSL, ERZL Amid Misinformation Concerns, Reaffirms Science-Backed Hydration Strategy - Medical Dialogues
Kenvue (KVUE) director Richard Allison awarded 1,331 deferred share units - Stock Titan
Kenvue Inc. $KVUE Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Cohen Capital Management, Inc.'s Kenvue Inc(KVUE) Holding History - GuruFocus
Kenvue Inc. $KVUE Shares Sold by DAVENPORT & Co LLC - MarketBeat
Kenvue Inc. (NYSE:KVUE) Short Interest Update - MarketBeat
Kenvue Inc (KVUE) Stock Price Quote Today & Current Price Chart - Capital.com
Kenvue Inc (KVUE) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Beacon Investment Advisory Services Inc. Sells 58,696 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Stock: Consumer Health Leader's Business Model, Competitive Position, and Investor Outlook IS - AD HOC NEWS
124,000 Shares in Kenvue Inc. $KVUE Acquired by CIBRA Capital Ltd - MarketBeat
DLK Investment Management LLC Sells 67,219 Shares of Kenvue Inc. $KVUE - MarketBeat
Wolff Wiese Magana LLC Has $73,000 Stake in Kenvue Inc. $KVUE - marketbeat.com
Kenvue Brands Release Skincare Innovations at AAD’s Annual Meeting - Happi | Household And Personal Products Industry
Vanguard disaggregates holdings; KVUE filings show 0 shares after realignment (KVUE) - Stock Titan
Neutrogena®, Aveeno® and Rogaine® release new dermatology research and clinical skincare innovations on healthy aging, moisturization, sun protection and acne - Kenvue
Neutrogena®, Aveeno® and Rogaine® Release New Dermatology Research and Clinical Skincare Innovations on Healthy Aging, Moisturization, Sun Protection and Acne - PR Newswire
Kenvue Inc Azioni (KVUE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.69%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):